ICH E6(R3) Guideline for Good Clinical Practice
Training Resources Available from Barnett

With the release of ICH E6(R3) (Annex 1), it is more important than ever for you and your clinical trial teams to implement an R3 training plan to ensure that all stakeholders are up to speed on the new requirements outlined in the ICH E6(R3) Guideline for Good Clinical Practice.

Barnett is here to assist with your clinical research compliance training needs during this transition, offering a variety of resources to ensure you're fully prepared, including:

Live, instructor-led training
Self-paced eLearning courses
ICH E6(R3)-focused publications

Course Customization

All of Barnett's ICH E6(R3) training can be customized for teams, and delivered virtually or in-person. For more details contact Barnett today!

Subject Matter Experts Leading ICH GCP E6(R3) Training

Nikki Christison, B.S., C.C.R.A., T.I.A.C.R.

Andy Lawton

Susan M. Leister, M.B.A., Ph.D., CQA, CSSBB

Marina Malikova, Ph.D., MSci, M.A., C.C.R.A., RAC

Shelia Russell McCullers, M.S., D.M.

Denise G. Redkar-Brown, MT

ICH E6(R3) FAQs

Is ICH E6(R3) implemented?
ICH E6(R3) final principles and Annex 1 were adopted in January 2025. Annex 2 is currently in draft form and currently open for public consultation.

What is new with ICH E6(R3) change?
The International Council for Harmonisation (ICH) has released the E6(R3) guidelines for Good Clinical Practice (GCP), introducing new terminology, revised principles and roles and responsibilities requirements, documentation and records guidance, and a new focus on data governance, all while maintaining a strong focus on participant safety and data integrity.

What are the key differences between ICH E6(R2) and ICH E6(R3)?
The key differences between ICH E6(R2) and ICH E6(R3) lie in the expanded focus on risk management, technology integration, and operational efficiency. While E6(R2) introduced a risk-based approach to clinical trials, emphasizing the identification, assessment, and mitigation of risks, E6(R3) takes this further by encouraging the use of advanced technologies. E6(R3) also places a stronger emphasis on patient-centered practices, flexible trial designs, and continuous quality management throughout the trial lifecycle. ICH E6(R3) also aligns more closely with global regulatory expectations and integrates new guidelines, aiming to streamline trial processes and improve collaboration among stakeholders.

Will ICH GCP(R3) impact my role within clinical research?
ICH GCP(E3) can impact you in several ways, depending on the specific role you have in clinical research. It’s important to understand the specific changes in the guidance and how they will affect the day-to-day execution of clinical trials and studies—along with how to integrate these changes into trial implementation.

How can Barnett International help me prepare for this transition?
Now is the time to implement your ICH GCP(R3) training plan. Barnett provides a wide range of resources that integrate the new guidance to help you navigate the ICH GCP(R3) transition:

An all-new GCP eLearning course that covers R3 content in detail, meeting the requirement for GCP training/refresher training.
Short courses covering key proposed changes, including the steps and processes clinical research organizations need to have in place.
Training on implementing RBQM and QbD programs that meet the expectations of R3.
An ICH E6(R3)-focused publication to clarify current interpretation and understanding of R3 requirements.
Customized ICH E6(R3) training for teams, delivered virtually or in-person.

ICH GCP E6(R3) Updates: Key Changes Impacting Sponsors and CROs

Oct 6, 2018, 18:23 PM

Title : ICH GCP E6(R3) Updates: Key Changes Impacting Sponsors and CROs

Course ID : 223

Acronym : CTCICH

Course Description

The release of ICH GCP E6(R3) represents a significant evolution in clinical trial management, building on the changes introduced in the R2 revision. With a focus on improving efficiency and adaptability in the face of growing trial complexity, the R3 updates bring more flexible and risk-based approaches to trial design, conduct, and oversight. This web seminar will guide participants through the essential updates in the ICH E6 guidelines, highlighting the direct impact on sponsors, CROs, and clinical trial teams. Practical strategies for incorporating these revisions into trial management processes will be explored, along with insights into how the R3 updates can streamline operational workflows while maintaining high standards of quality and compliance. Specific topics include the evolving roles of sponsors and CROs in this updated framework.

Learning Objectives

Identify three key changes in the ICH GCP E6(R3) updates that affect sponsors and CROs, along with their impact on individual roles
Explain how the revisions influence clinical trial conduct and organizational practices
Discuss practical opportunities for implementing the revised guideline to improve trial management efficiency and compliance

Who Should Attend

Managers/Directors: Clinical Operations, Clinical Research, Data Management, Quality Management, Compliance, Process Improvement, Risk Management, Quality Risk Management
Study Managers/Project Managers, Clinical Research Associates/ Monitors (Centralized, On-site)

Instructor

The course will be led by one of the following instructors:

Nikki Christison, B.S., C.C.R.A., T.I.A.C.R.

Susan M. Leister, M.B.A., Ph.D., CQA, CSSBB

Shelia Russell McCullers, M.S., D.M.

Click here for complete trainer biographies

Registration Fees

$835*

*Includes up to 20 participants per login at a single location. All participants (up to 20) are eligible for “Certificates of Attendance,” and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional logins for other locations, please call +1 781.972.5400 or toll-free in the U.S. 800.856.2556, or email customer.service@barnettinternational.com for pricing.

Accreditation Information

Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 2 hours (0.2 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation. Barnett International will issue a receipt of completion for earned CEUs within three weeks of program completion. ACPE#:0778-0000-25-031-L99-P. Released: 4/25.

Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471.

Series :